NCT03948256

Brief Summary

The DRAIN trial is an international multi-centre, 1:1 randomised, parallel-group, superiority clinical trial investigating gradual weaning vs. prompt closure of external ventricular drainage in patients with hydrocephalus following aSAH. The primary objective is to investigate the beneficial and harmful effects of gradual weaning versus prompt closure of EVD treatment in patients with aSAH.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
245

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 13, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

June 6, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

5 years

First QC Date

April 4, 2019

Last Update Submit

June 24, 2024

Conditions

Keywords

External ventricular drainWeaningClosureControlled trialRandomised trialOutcome assessment blinded

Outcome Measures

Primary Outcomes (1)

  • VP-shunt implantation, all-cause mortality, or EVD-related infection.

    The primary outcome is a composite outcome of VP-shunt implantation, all-cause mortality, and EVD-related infection.

    6 months after ictus

Secondary Outcomes (2)

  • Number of serious adverse events (SAE) not including death

    6 months after ictus

  • Health-related quality of life (EQ-5D-5L)

    6 months after ictus

Other Outcomes (7)

  • Functional outcome according to modified Rankin Scale

    6 months after ictus

  • The remaining dimensions of EQ-5D-5L

    6 months after ictus

  • Fatigue Severity Scale (FSS)

    6 months after ictus

  • +4 more other outcomes

Study Arms (2)

Control intervention

ACTIVE COMPARATOR

Prompt closure, based on best available scientific data

Procedure: Control intervention

Experimental intervention

EXPERIMENTAL

Gradual weaning, based on best available scientific data

Procedure: Experimental intervention

Interventions

Prompt closure of EVD with subsequent observation period

Also known as: Prompt closure
Control intervention

Gradual weaning of EVD with 5 cmH2O increase in drainage resistance daily until complete closure with subsequent observation period

Also known as: Gradual weaning
Experimental intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>= 18 years of age
  • Diagnosis of aneurysmal subarachnoid haemorrhage (aSAH)
  • External ventricular drain (EVD) for \>= 6 days
  • Drain output of =\< 220 mL on day of randomisation
  • Drain resistance of 10 or 15 cm H2O
  • Stable or improving Glasgow Coma Scale (GCS) \>= 9 during the last 24 hours
  • Signed informed consent (from patient or next-of-kin)

You may not qualify if:

  • None-tolerability of an increase of resistance to 10 cm H2O due to clinical deterioration or an increase in ICP
  • Severe pre-existing (physical or mental) disability or severe co-morbidity that would lead to poor outcome even if the patient made a full recovery from the aSAH
  • Life expectancy shorter than 48 hours after admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Neurosurgery, Odense University Hospital

Odense, Region Syd, 5000, Denmark

Location

Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet

Copenhagen, 2100, Denmark

Location

Department of Neurosurgery, Oslo University Hospital

Oslo, Norway

Location

Department of Neurosurgery, University Hospital of North Norway

Tromsø, Norway

Location

Related Publications (2)

  • Capion T, Lilja-Cyron A, Juhler M, Moller K, Sorteberg A, Ronning PA, Poulsen FR, Wismann J, Schack AE, Ravlo C, Isaksen J, Lindschou J, Gluud C, Mathiesen T, Olsen MH. Prompt closure versus gradual weaning of external ventricular drain for hydrocephalus following aneurysmal subarachnoid haemorrhage: a statistical analysis plan for the DRAIN randomised clinical trial. Trials. 2024 Jul 15;25(1):479. doi: 10.1186/s13063-024-08305-4.

  • Capion T, Lilja-Cyron A, Olsen MH, Juhler M, Moller K, Sorteberg A, Ronning PA, Poulsen FR, Wismann J, Ravlo C, Isaksen J, Lindschou J, Gluud C, Mathiesen T. Prompt closure versus gradual weaning of external ventricular drainage for hydrocephalus following aneurysmal subarachnoid haemorrhage: Protocol for the DRAIN randomised clinical trial. Acta Anaesthesiol Scand. 2023 Sep;67(8):1121-1127. doi: 10.1111/aas.14263. Epub 2023 May 10.

MeSH Terms

Conditions

Subarachnoid HemorrhageHydrocephalus

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Tiit I Mathiesen, DMSc

    Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the intervention with two arms with different time course it is not possible to mask patients nor investigators or care providers
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1:1 randomisation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 4, 2019

First Posted

May 13, 2019

Study Start

June 6, 2019

Primary Completion

June 18, 2024

Study Completion

June 18, 2024

Last Updated

June 25, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Data wille be available upon reasonable request and only after approval from local authorities and involving parties.

Locations